Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
INJECTABLE VACCINES AGAINST MULTIPLE MENINGOCOCCAL SEROGROUPS
No-Receipt date
2012-01736 - 31/05/2012
No-Filing date
20120401241 - 31/05/2012
No-Granting date
3078118 - 31/05/2012
No-EPO application date
04706762.4 - 30/01/2004
No-EPO granting date
1587537 - 11/04/2012
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
5/2012 - 14/06/2012
Expiration date
31/01/2024
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
GB030221730/01/2003/GB
GB032310102/10/2003/GB
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07K 14/22
A61K 39/39
A61K 39/095
A61K 39/09
A61K 39/02
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
683342
GLAXOSMITHKLINE BIOLOGICALS S.A.
RUE DE L`INSTITUT, 89
1330 RIXENSART, BELGIUM
BELGIUM
Inventors
Code
Firstname
Surname
994198
COSTANTINO, PAOLO, CHIRON S.R.L.
Representatives
Code
Firstname
Surname
Address
Town
Zip
3178
STEFANOS ALEXIOS
TSIMIKALIS "TSIMIKALIS KALONAROU DIKIGORIKI ETAIREIA"
NEOFYTOU VAMVA 1
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
8126
STEFANOS ALEXIOS
TSIMIKALIS
NEOFYTOU VAMVA 1
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
21/09/2017
Μεταβίβαση (7e802)
Α.Π.4003-Η.Θ.9251/18-7-17,ΔΝΥ1187,ΚΩΔ.ΠΛΗΡ.3190
419049 Novartis AG Lichtstrasse 35 ΕΛΒΕΤΙΑ 4056 Basel
683342 GlaxoSmithKline Biologicals S.A. Rue de l`Institut, 89 ΒΕΛΓΙΟ 1330 Rixensart, BELGIUM
Title Instruments
Date
Operation
Descreption
8/5/2021 12:00:00 AM
Έκπτωση Κύριων Τίτλων (79602)
ΕΚΠΤΩΣΕΙΣ 07/2021 Αρ. Πρωτ. ΓΔ 1464 / 05.08.2021
Payments history
17 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).